Jubilant News! CenturyKangtai's Intraocular Lens Listed in the 'Directory of Outstanding Domestic Medical Equipment Products'

Aug 07, 2024 12:02 CST Updated 12:02

Century Healthcare

Medical Device Manufacturer, R&D, and Distributor

Click to follow?｜Focus on Global Biomedical Investment

On July 30, the selection and evaluation results of the "Tenth Batch of Excellent Chinese Medical Device Products Directory" organized by the China Medical Equipment Association were announced.Century Healthcare's independently developed new generation of preloaded all-purpose hydrophobic intraocular lenses made the list!This selection marks that the product has reached a leading level in China in terms of technical performance, clinical application effectiveness, and corporate performance.Yifeng Capital participated in the investment of Century Healthcare in 2023.

The all-new generation of preloaded multifunctional hydrophobic acrylic intraocular lens is an innovative achievement developed by Century Healthcare after many years of research. It was approved by the National Medical Products Administration for the Class III medical device certification on July 12, 2023; selected for the fourth batch of high-value medical consumables national procurement on November 30, 2023, and included in the procurement list of more than 2,000 public hospitals; implantation and use across China will gradually commence in June 2024.This crystal is also one of the several premium products independently developed and designed by Century Healthcare.Designed based on Century Healthcare's Mercury intraocular lens platform, featuring multiple leading technologies:

✦

•

1. The first Monte Carlo optimization in China - 0.1μm spherical aberration settingPlan：This design not only achieves a large depth of focus and excellent visual quality but also significantly improves contrast sensitivity, providing patients with a clearer and more comfortable visual experience. Meanwhile, the -0.1μm spherical aberration design excels in effectively resisting tilt and decentration as well as expanding the depth of focus range, further enhancing the clinical application outcomes of the product.

✦

•

2. A New Generation of Hydrophobic Acrylic Material First Developed in China:Not only does it combine both hydrophilic and hydrophobic advantages, but also utilizes a unique "HydroBalance Technology" to gradually saturate to nearly 4% water content after IOL implantation in the eye, achieving a flash-free effect similar to hydrophilic intraocular lenses, further enhancing patient comfort.

✦

•

3. All-round aspheric hydrophobic acrylic edge design:360° full-angle design, comprehensively blocks the migration of lens epithelial cells, effectively reducing the incidence of PCO; reinforced stable support processing technology ensures a closer adhesion between the intraocular lens and the posterior capsule as well as good stability and centration after implantation.

✦

•

4. Globally Leading Pre-installed System：Making the surgical operation more convenient and faster, reducing the surgical risk.

About Century Healthcare

Century Healthcare is a Class III high-end medical device manufacturing enterprise that integrates research and development, production, and sales. Relying on excellent scientific research platforms, and guided by the strategic direction of an "innovative ophthalmic materials and optical design platform," Century Healthcare covers areas such as intraocular lenses, optometry, and biomaterials like collagen. It currently has more than 20 products applied in ophthalmology, surgery, and medical aesthetics.

The company has obtained more than 80 invention patents and utility model patents, with 8 Class III medical device registration certificates and 3 Class II medical device registration certificates approved by the National Medical Products Administration. In addition, the company's intraocular lens products have also obtained foreign certifications such as CE certification.

In 2023, Century Healthcare's multifocal, extended depth-of-field and other high-end intraocular lenses, scleral lenses, and orthokeratology lenses have all completed clinical enrollment. The company has now become an "innovative ophthalmic materials and optical technology platform enterprise" with a presence in the fields of cataract refractive surgery, optometry, and biomaterials such as collagen.

It is currently one of the few companies in China's ophthalmology field that simultaneously masters core technologies such as the optical design, processing, and production of hydrophilic, hydrophobic, single-focus, and multi-focus intraocular lenses. Among these, the "-0.1μm spherical aberration design," "edge-enhanced zero spherical aberration," "hollow haptics," and "625 large optical zone" are all domestic firsts for aspheric intraocular lenses in China. Moreover, its collagen sponge product was granted the first Class III medical device registration certificate for full surgical use by the National Medical Products Administration under the new standards since 2011.